CMS Administrator Verma unveils new strategy to fuel data-driven patient care, transparency

26 April 2018 - New Medicare Advantage data resource released. ...

Read more →

Post-marketing modifications of drug labels for cancer drugs approved by the US FDA between 2006 and 2016 with and without supporting randomized controlled trials

11 April 2018 - Modifications in cancer drug indications, dosing, and related toxicities after FDA approval are common. It is unclear ...

Read more →

Guilty: Health Department breached privacy laws publishing data of 2.5 million people

29 March 2018 - The federal Department of Health "unintentionally" breached privacy laws when it published de-identified health records of ...

Read more →

A revolution in health care is coming

 1 February 2018 - Welcome to Doctor you. ...

Read more →

ICER’s guideline on the acceptance and use of “in-confidence” data from manufacturers of pharmaceuticals, devices, and other health care interventions

22 December 2017 - ICER takes its obligations to transparency and fairness seriously.  ...

Read more →

Not so anonymous: Medicare data can be used to identify individual patients, researchers say

18 December 2017 - Researchers say they can identify individuals in government healthcare data that was supposed to be anonymous, ...

Read more →

Report on the collection of under co-payment data 2016-17

14 December 2017 - From 1 July 2016 to 30 June 2017, approximately 85 million under co-payment prescriptions were supplied ...

Read more →

Canada's regulator of patented drug prices is rigging data, and risking our health

5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...

Read more →

Is the FDA withholding data about a controversial drug to protect its manufacturer?

29 November 2017 - In the case of Sarepta, it sure looks that way. ...

Read more →

Chemotherapy compounder ID mandatory within PBS claims from 1 December 2017

22 November 2017 - From 1 December 2017, approved suppliers (approved pharmacists, approved medical practitioners and approved public and private ...

Read more →

New 'powerful' cancer website for doctors

22 November 2017 - Quality national data on cancer in Australia is now available to clinicians via the National Cancer Control ...

Read more →

Use of health care databases to support supplemental indications of approved medications

20 November 2017 - Can health care databases be used to confirm a supplemental indication that has been demonstrated in a ...

Read more →

Can ad hoc analyses of clinical trials help personalise treatment decisions?

23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...

Read more →

Unparalleled access to clinical data - one year on

20 October 2017 - Over 3,000 clinical documents published, 3,600 registered users and positive stakeholder feedback. ...

Read more →

Payers need access to pre-approval drug information

19 October 2017 - Healthcare payment in the United States is shifting toward value—a transformation that will require new approaches ...

Read more →